Hepatocellular carcinoma: Updates in primary prevention

被引：6

作者：

Fecht Jr. W.J. ^{[1
]}

Befeler A.S. ^{[1
]}

机构：

[1] Div. of Gastroenterology/Hepatology, Saint Louis Univ. School of Medicine, St. Louis, MO 63110-0250

来源：

Current Gastroenterology Reports | 2004年 / 6卷 / 1期

关键词：

Hepatocellular Carcinoma; Aflatoxin; Sustained Virologic Response; Glycyrrhizin; Hereditary Hemochromatosis;

D O I：

10.1007/s11894-004-0024-3

中图分类号：

学科分类号：

摘要：

Hepatocellular carcinoma is a significant cause of mortality worldwide and a growing problem in the United States. Treatment options are often limited, and median survival is less than 1 year, Thus, prevention may provide the best opportunity to alter the natural history of this disease. Primary prevention is best exemplified by the successes of such public health measures as universal hepatitis B vaccination. Such antiviral therapies as interferon may also have a role. Lessons can be learned from complementary and alternative medicine, Nevertheless, more work is needed in understanding hepatocarcinogenesis and in developing models to assess potential chemopreventive agents. Copyright © 2004 by Current Science Inc.

引用

页码：37 / 43

页数：6

共 49 条

[1] Befeler A.S., Di Bisceglie A.M., Hepatocellular carcinoma: Diagnosis and treatment, Gastroenterology, 122, pp. 1609-1619, (2002)
[2] Bosch F.X., Ribes J., Borras J., Epidemiology of primary liver cancer, Semin. Liver Dis., 19, pp. 271-285, (1999)
[3] El-Serag H.B., Mason A.C., Rising incidence of hepatocellular carcinoma in the United States, N. Engl. J. Med., 340, pp. 745-750, (1999)
[4] Jemal A., Murray T., Samuels A., Et al., Cancer statistics 2003, CA Cancer J. Clin., 53, pp. 5-26, (2003)
[5] El-Serag H.B., Davila J., Petersen N., The incidence of hepatocellular carcinoma in the United States: Is it still rising?, Gastroenterology, 124, SUPPL. 1, (2003)
[6] Thorgeirsson S.S., Grisham J.W., Molecular pathogenesis of human hepatocellular carcinoma, Nat. Genet., 31, pp. 339-346, (2002)
[7] Nzeako U.C., Goodman Z.D., Ishak K.G., Hepatocellular carcinoma in cirrhotic and noncirrhotic livers: A clinico-histopathologic study of 804 North American patients, Am. J. Clin. Pathol., 105, pp. 65-75, (1996)
[8] El-Serag H.B., Epidemiology of hepatocellular carcinoma, Clin. Liver Dis., 5, pp. 87-107, (2001)
[9] El-Serag H.B., Mason A.C., Key C., Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in United States, Hepatology, 33, pp. 62-65, (2001)
[10] Blum H.E., Molecular targets for prevention of hepatocellular carcinoma, Dig. Dis., 20, pp. 81-90, (2002)

← 1 2 3 4 5 →